Imatinib has been widely used to treat BCR-ABL positive CML in clinic32 while etoposide has been used to treat a variety of cancers29 including leukemia in certain clinical settings33. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.